BIOMERICA, INC. (NASDAQ:BMRA) Files An 8-K Other Events
Item 8.01 Other Events
On March 17, 2020, Biomerica, Inc., issued the attached press release.
99.1 Press Release
BIOMERICA INC Exhibit
EX-99.1 2 exhibit99_1.htm EXHIBIT 99.1 Exhibit 99.1 Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure – 10-minute test for coronavirus exposure utilizing blood from a finger prick can be performed anywhere by trained professionals,…
To view the full exhibit click
About BIOMERICA, INC. (NASDAQ:BMRA)
Biomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company’s medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians’ offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company’s diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company’s diagnostic products use immunoassay technology.